Routine severance amendment with no trading signal. Monitor the Q3 2026 10-Q for full agreement exhibits if detail on base salary and bonus targets is needed. No immediate catalyst for KURA shares.
Price Chart
Executive Summary
Kura Oncology entered amended executive employment agreements with its CEO, CCO, and COO modifying severance provisions. The changes enhance change-of-control severance benefits (e.g., 24-month salary for CEO in change-of-control termination, full equity acceleration). No departures, appointments, or material financial figures were disclosed.
Key Facts
- CEO Troy E. Wilson's new agreement provides 12 months base salary severance (non-change-of-control) or 24 months + 200% target bonus (change-of-control).
- CCO Brian Powl and COO Kathleen Ford each receive 12 months base salary severance (non-change-of-control) or 18 months + 150% target bonus (change-of-control).
- Change-of-control severance includes full equity acceleration (performance-based awards vest at target) for all three executives.
- Full copies of the agreements will be filed with the Q3 2026 10-Q.
Financial Impact
No dollar amounts disclosed; impact is contingent on undefined severance scenarios (base salary and target bonus values not provided).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-324202 |
| Document: 0001193125-26-324202-index-headers.html | 0001193125-26-324202 |
| Document: 0001193125-26-324202-index.html | 0001193125-26-324202 |
| Document: 0001193125-26-324202.txt | 0001193125-26-324202 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $12.09 $11.37 | ▼ −6.00% | ▼ −5.66% | $10.65 (−11.91%) |
Sep 8, 2026 24d ago | 8-K | $12.52 $11.30 | ▼ −9.74% | ▼ −8.63% | $10.65 (−14.94%) |
Aug 24, 2026 5w ago | Insider Cluster | $12.40 $12.65 | ▲ +2.02% | ▲ +1.55% | $10.65 (−14.11%) |
Aug 21, 2026 6w ago | Insider Cluster | $11.89 $12.66 | ▲ +6.48% | ▲ +6.00% | $10.65 (−10.43%) |
Aug 17, 2026 6w ago | Insider Buy | $12.33 $13.59 | ▲ +10.22% | ▲ +10.42% | $10.65 (−13.63%) |
Aug 12, 2026 7w ago | Press Release | $10.09 $11.71 | ▲ +16.06% | ▲ +18.02% | $10.65 (+5.55%) |
Aug 5, 2026 8w ago | Press Release | $9.20 $9.94 | ▲ +8.04% | ▲ +7.69% | $10.65 (+15.76%) |
Jul 29, 2026 9w ago | 8-K | $9.31 $9.28 | ▼ −0.32% | ▼ −3.94% | $10.65 (+14.39%) |
Jul 14, 2026 11w ago | Press Release | $11.24 $10.68 | ▼ −4.98% | ▼ −3.69% | $10.65 (−5.25%) |
Jun 3, 2026 17w ago | Press Release | $8.66 $8.68 | ▲ +0.29% | ▲ +4.11% | $10.65 (+23.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access